Choose monthly or annual.

One product, two ways to pay. Lock in the early-access rate — kept for as long as you stay subscribed, even after we raise the standard rate. Cancel anytime.

Limited-time early access — lock in $15/mo (reg. $25) or $150/yr (reg. $250), forever
Monthly
$25 $15 /month
Early-access rate — locked in for life. Regular price $25/mo.
Start monthly — $15/mo →
  • All 90 strategies — full backtests, model portfolios, exit-method comparison
  • Watchlist + signal alerts
  • Unlimited custom backtests (no daily cap)
  • Options snapshot · Fear & Greed index · Biotech calendar
  • Save + share custom strategies (referral attribution)
  • Early-access rate locked — never raised on you
  • Cancel anytime · refund within 30 days if unused
Annual save $30/yr
$250 $150 /year
$12.50/mo equivalent · locked in for life. Regular price $250/yr.
Start annual — $150/yr →
  • All 90 strategies — full backtests, model portfolios, exit-method comparison
  • Watchlist + signal alerts
  • Unlimited custom backtests (no daily cap)
  • Options snapshot · Fear & Greed index · Biotech calendar
  • Save + share custom strategies (referral attribution)
  • Early-access rate locked — never raised on you
  • Cancel anytime · refund within 30 days if unused
Public data only — every number sourced
Cancel anytime — one click in your account
Limited-time rate — locked in, never raised on you

Common questions

Is there a free version?

No traditional free tier — but the home page shows one rotating "strategy of the week" with full backtest stats and all exits tested, so you can see what the product looks like before subscribing. Everything else (the full 90-strategy library, watchlist, alerts, options + fear & greed pages) requires a subscription.

How long is the early-access price available?

Early access is a limited-time offer. Subscribe while it's open and your rate — $15/mo or $150/yr — is locked in for life, for as long as you stay subscribed, even after the rate goes back to the standard $25/mo. If you cancel and re-subscribe later you'd pay the then-current rate.

Where does the data come from?

100% public primary sources: SEC EDGAR (insider Form 4 / 8-K / 13F / 13D), House Clerk + Senate disclosures, openFDA, ClinicalTrials.gov, USAspending.gov contracts, Senate LDA lobbying, FEC contributions, BLS / FRED / EIA macro feeds. Every signal on the dashboard links back to its primary source — you can verify any number yourself.

Can I switch between monthly and annual later?

Yes — open your account page and click "Manage subscription" to switch billing cadence. Stripe pro-rates the change automatically.

What's your refund policy?

Email feedback@stockpolitics.com within 30 days of your first charge and we'll refund it, no questions. After that, you can cancel from your account page at any time — you keep access through the end of the current period.

Is this investment advice?

No. Stock Politics surfaces patterns in public disclosure data — what Congress is trading, what insiders are filing, which companies are getting government contracts. We backtest those patterns historically. None of it is a recommendation. Trade your own money at your own risk.